4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...tandardised questionnaires and the Global TB Drug Facility website.
more
Cureus 16(2): e53933. DOI 10.7759/cureus.53933
BMJ Open Science 2021;5:e100202. doi:10.1136/
bmjos-2021-100202
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
WHO Annual Meeting with Pharmaceutical Companies and Stakeholders
08 March 2016, Geneva
2015-06-03 - Board presentation - v32.pptx
New England Journal of Medicine 374:1,pp23-32
Lancet Glob Health 2020Published OnlineDecember 10, 2020 https://doi.org/10.1016/S2214-109X(20)30460-5
The African region reports the highest number of health emergencies of all the WHO regions every year: an average of
2-3 new events every week
Southern African Journal of HIV Medicine
ISSN: (Online) 2078-6751, (Print) 1608-9693
http://www.sajhivmed.org.za
Published: 23 May 2018
This casebook collects 64 case studies, each of which raises an important and difficult ethical issue connected with planning, reviewing, or conducting health-related research. The book’s purpose is to contribute to thoughtful analysis of these issues by researchers and members of research ethics ...committees (RECs, known in some places as ethical review committees or institutional review boards), particularly those involved with studies that are conducted or sponsored internationally.
more
Nature | Vol 600 | 2 December 2021 |
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Orientations provisoires 19 juillet 2021
AIDSTAR-One | CASE STUDY SERIES November 2012